IdentifySensors Biologics, a Purdue University-affiliated technology firm developing a rapid diagnostic platform for detecting pathogens, including SARS-CoV-2, has entered into a new partnership with Purdue Research Foundation and will open an office in Purdue’s Discovery Park District.
As the COVID-19 pandemic was about to break around the globe, IdentifySensors, the parent company of IdentifySensors Biologics, had approached Purdue to help it develop a nanosensor designed to detect spoilage and specific pathogens in the food supply chain.
When the pandemic became apparent, the company pivoted to start working with Purdue researcher Lia Stanciu, associate head and professor of materials engineering, to develop a rapid diagnostic platform for detecting SARS-CoV-2, the virus that causes COVID-19.
IdentifySensors Biologics has partnered with PRF and has opened an office in the Convergence Center for Innovation and Collaboration in Purdue’s Discovery Park District. PRF is investing $50,000 in IdentifySensors.
MEDIA & PRESS INQUIRES
CONNECT WITH IDENTIFYSENSORS
Communications: Joe Mosbrook
(216) 375-2141
mosbrook@acclaimllc.com
Related Articles
Ohio doctor develops fast self-testing for COVID-19
MEDIA & PRESS INQUIRES CONNECT WITH IDENTIFYSENSORS Communications: Joe Mosbrook (216) 375-2141 mosbrook@acclaimllc.comRelated Articles
Check4-COVID by IdentifySensors Biologics Allows For Accurate Results Within Minutes On Your Phone
MEDIA & PRESS INQUIRES CONNECT WITH IDENTIFYSENSORS Communications: Joe Mosbrook (216) 375-2141 mosbrook@acclaimllc.comRelated Articles
Bloomberg Business – IdentifySensors Biologics Develops Fast, Accurate, Over-the-counter RNA COVID Self-test
MEDIA & PRESS INQUIRES CONNECT WITH IDENTIFYSENSORS Communications: Joe Mosbrook (216) 375-2141 mosbrook@acclaimllc.comRelated Articles